JUNE 01, 2006

Drug-sales-representative computerized data on what physicians are prescribing is coming under attack by some physicians. The data gathering can help the estimated 90,000 drug-company representatives influence physicians to write more prescriptions for a brand name drug or fewer scripts for a competitor's drug.

New Hampshire, Arizona, Hawaii, and West Virginia have all introduced separate legislation to squash the practice. In an attempt to mollify physicians and put off state restrictions, the American Medical Association (AMA) plans to give individual physicians the option of declaring their prescription records off limits to drug sales representatives.

In California, one of the states that raised complaints about the practice, a group of physicians is starting a pilot program under which physicians who opt out of the AMA system will get comparisons of their prescribing patterns in 17 classes from the data companies.

State Rep Cindy Rosenwald (D), lead sponsor of New Hampshire's bill, said that she did not feel the AMA's self-policing measure would provide sufficient protection. Even if physicians do not permit their prescription records to be available to drug-sales representatives, the information would still be sold to drug companies for marketing and research purposes, Rosenwald said. The drug companies would have to be trusted not to share the data with their sales staff, she added.

A 2004 Gallup poll found that two thirds of physicians surveyed were against the release of such data to sales representatives, and that 77% believed that an optout program would ease concerns about the data release. Nearly 25% of the physicians, however, were unaware that the pharmaceutical industry could obtain the information.


Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?

Pharmacy Times Strategic Alliance

Pharmacist Education
Clinical features with downloadable PDFs

Next-Generation Pharmacist® Awards

3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference

Personalize the information you receive by selecting targeted content and special offers.